GlassScriptPhysician profile
Tirth A Patel
NPI 1619436698
$4,538.55
in general payments reported to CMS, 2019-2025
16 companies · $2,964 in 2025
The $2,964 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $73.25 · 2024: $1,501 · 2025: $2,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,986 · Travel and Lodging: $1,458 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,985.73 |
| Travel and Lodging | $1,457.83 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $2,290.19 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $954.19 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Jeti |
| Abiomed | $292.37 | 2024-2025 | Impella |
| Actelion Pharmaceuticals US, INC. | $285.60 | 2025 | Opsumit, Uptravi, Opsynvi |
| Novo Nordisk INC | $151.47 | 2025 | Ozempic, Wegovy |
| Pfizer INC. | $116.87 | 2023-2025 | |
| One Lambda, INC. | $94.03 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.22 | 2024-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $40.77 | 2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $36.01 | 2023 | Xarelto |
| Impulse Dynamics (USA) INC. | $35.47 | 2025 | Optimizer |
| Takeda Pharmaceuticals U.S.A., INC. | $34.33 | 2025 | Livtencity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.80 | 2024-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $31.34 | 2024-2025 | |
| La Jolla Pharmaceutical Company | $29.49 | 2024 | Giapreza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $23.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tirth Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.